Whole-genome sequencing and comprehensive molecular profiling identify new driver mutations in gastric cancer

By Kai Wang, S. Yuen, Jiangchun Xu, Siu Po Lee, Helen H. N. Yan, S. Shi, H. Siu, Shibing Deng, K. Chu, S. Law and 18 more. Nature Genetics, 2014

1,008 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Prospective derivation of a Living Organoid Biobank of colorectal cancer patients (2015, background): “Recent sequencing efforts of gastric, ovary, and pancreatic neoplasias identified RNF43 mutations (Jiao et al., 2014; Ryland et al., 2013; Wang et al., 2014), and RNF43 mutations have been observed in 936 Cell 161, 933–945, May 7, 2015 ª2015 Elsevier Inc. CRC (Giannakis et al., 2014; Ivanov et al.,…”
OncodriveFML: a general framework to identify coding and non-coding regions with cancer driver mutations (2016, methodology): “…mutations of seven cancer types (breast invasive carcinoma, chronic lymphocytic leukemia, liver cancer, lung adenocarcinoma, lymphoma B-cell, medulloblastoma, and pilocytic astrocytoma) extracted from the work by Alexandrov et al. [20] plus a supplementary stomach adenocarcinoma dataset [41].”